Hongbo Pharmaceuticals: Shareholder Hongbo Zhiguan intends to transfer 5% of the shares through inquiry.

Hongbo Pharmaceuticals announcement, shareholder Hongbo Zhiyuan Pharmaceutical Technology Co., Ltd. intends to transfer 6.9793 million shares through inquiry transfer method, accounting for 5.00% of the total share capital of the company, 5.07% excluding the repurchase special account, and 18.05% of the holdings; the minimum transfer price is 70% of the average stock trading price of the last 20 trading days before December 24, 2025; the transferee must be an institutional investor with pricing capability and risk-bearing ability, and the shares obtained cannot be transferred within 6 months; CITIC Securities is responsible for organizing and implementing the transfer.